LivaNova PLC

LIVNNASDAQ · USD
76.63USD0.00 (+1.58%)
799

LivaNova PLC (LIVN) Options Open Interest

LIVN options open interest is 386 contracts. The 2-week average daily volume is 6 contracts across the chain.

Read more

Monitoring LIVN open interest helps you see where real money is positioned on LivaNova PLC's options and which strikes are attracting the most commitment from traders. LivaNova PLC's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor LIVN options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising LIVN options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect LivaNova PLC to settle.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea.

It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where LIVN open interest is concentrated. Our scanner maps LivaNova PLC's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade LivaNova PLC's options open interest as the signal it is, not as an afterthought.

2026-10-16
Calls
90.00—2.152.1580%+0.25555
60.0015.4019.2017.3010%+1.00003
55.0020.4024.2022.3047%+0.99852
70.007.0010.008.5051%+0.80082
85.00—1.501.5053%+0.25942
Puts
75.000.903.402.1542%-0.36463
85.006.609.307.9531%-0.88473
37.50—1.151.15215%-0.05281
45.00—2.152.15204%-0.09341
70.00—3.003.0082%-0.27701

As of September 25, 2026

Follow the money

Track LIVN open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial